About Jnana Therapeutics
Jnana Therapeutics is a private company based in Boston, Massachusetts. It has reported $156,999,997 raised in two offerings on Form D since August 2021. Its chief executive is Joanne Kotz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 2, 2022 | Nov 16, 2022amended Jan 26, 2024 | $106,999,997fully sold | 8 | $13.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 12, 2021 | Aug 24, 2021 | $50,000,000fully sold | 14 | $3.5M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $156,999,997 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Jnana Therapeutics's Form D filed Jan 26, 2024.
AC
Annie Chen
Director
DP
Douglas Pagan
Chief Financial Officer and Chief Operating Officer
RJ
Ronald Renaud, Jr.
Director
GV
George Vratsanos
Chief Medical Officer and Head of R&D
CR
Carlo Rizzuto
Director
TM
Terrance McGuire
Director
JK
Joanne Kotz
Chief Executive Officer, Treasurer, Secretary and Director
DN
Donald Nicholson
Director
CB
Caroline Beer
Chief Business Officer
MH
Matthew Hammond
Director
BC
Brian Cali
Director
Earlier filings also listed Stuart Schreiber (director, last listed Aug 2021), Kevin Kinsella (director, last listed Aug 2021) and Joel Barrish (chief scientific officer, last listed Aug 2021).